Rebecca Smith-Bindman
Biographic Data
| ID | 5534334 |
|---|---|
| NAME | Rebecca Smith-Bindman |
| GIVEN NAMES | Rebecca |
| FAMILY NAME | Smith-Bindman |
| SIGNATURE | SMITH-BINDMAN R |
| VERIFIED | No |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 0 |
Cost Analysis of the STONE Randomized Trial
BACKGROUND: Decreasing the use of high-cost tests may reduce health care costs. OBJECTIVE: To compare costs of care for patients presenting to the emergency department (ED) with suspected kidney stones randomized to 1 of 3 initial imaging tests. RESEARCH DESIGN: Patients were randomized to point-of-care ultrasound (POC US, least costly), radiology ultrasound (RAD US), or computed tomography (CT, most costly). Subsequent testing and treatment were…
Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography
BACKGROUND: The breast cancer detection rate is a benchmark measure of screening mammography quality, but its computation requires linkage of mammography interpretive performance information with cancer incidence data. A Medicare claims-based measure of detected breast cancers could simplify measurement of this benchmark and facilitate mammography quality assessment and research. OBJECTIVES: To validate a claims-based algorithm that can identify …
Distinguishing Screening From Diagnostic Mammograms Using Medicare Claims Data
BACKGROUND: Medicare claims data may be a fruitful data source for research or quality measurement in mammography. However, it is uncertain whether claims data can accurately distinguish screening from diagnostic mammograms, particularly when claims are not linked with cancer registry data. OBJECTIVES: To validate claims-based algorithms that can identify screening mammograms with high positive predictive value (PPV) in claims data with and witho…
Facility Characteristics do not Explain Higher False-positive Rates in Diagnostic Mammography at Facilities Serving Vulnerable Women
BACKGROUND: Facilities serving vulnerable women have higher false-positive rates for diagnostic mammography than facilities serving nonvulnerable women. False positives lead to anxiety, unnecessary biopsies, and higher costs. OBJECTIVE: Examine whether availability of on-site breast ultrasound or biopsy services, academic medical center affiliation, or profit status explains differences in false-positive rates. DESIGN: We examined 78,733 diagnost…
Accuracy of Diagnostic Mammography at Facilities Serving Vulnerable Women
BACKGROUND: Breast cancer missed on diagnostic mammography may contribute to delayed diagnoses, whereas false-positive results may lead to unnecessary invasive procedures. Whether accuracy of diagnostic mammography at facilities serving vulnerable women differs from other facilities is unknown. OBJECTIVE: To compare the interpretive performance of diagnostic mammography at facilities serving vulnerable women to those serving nonvulnerable women. …
An Assessment of the Quality of Mammography Care at Facilities Treating Medically Vulnerable Populations
BACKGROUND: Women in medically vulnerable populations, including racial and ethnic minorities, socioeconomically disadvantaged, and residents of rural areas, experience higher breast cancer mortality than do others. Whether mammography facilities that treat vulnerable women demonstrate lower quality of care than other facilities is unknown. OBJECTIVES: To assess the quality of mammography women receive at facilities characterized as serving a hig…
Can Medicare Billing Claims Data Be Used to Assess Mammography Utilization Among Women Ages 65 and Older
BACKGROUND: Medicare data may be a useful source for determining the utilization of mammography among elderly women, but the accuracy of these data has not been established. OBJECTIVE: We determined whether Medicare physician billing claims are an accurate reflection of mammography utilization among women ages 65 and older and whether they can be used to assess the use of screening as compared with diagnostic mammography. DATA SOURCES: Mammograph…
No prominent works on this page.
Can Medicare Billing Claims Data Be Used to Assess Mammography Utilization Among Women Ages 65 and Older
BACKGROUND: Medicare data may be a useful source for determining the utilization of mammography among elderly women, but the accuracy of these data has not been established. OBJECTIVE: We determined whether Medicare physician billing claims are an accurate reflection of mammography utilization among women ages 65 and older and whether they can be used to assess the use of screening as compared with diagnostic mammography. DATA SOURCES: Mammograph…
An Assessment of the Quality of Mammography Care at Facilities Treating Medically Vulnerable Populations
BACKGROUND: Women in medically vulnerable populations, including racial and ethnic minorities, socioeconomically disadvantaged, and residents of rural areas, experience higher breast cancer mortality than do others. Whether mammography facilities that treat vulnerable women demonstrate lower quality of care than other facilities is unknown. OBJECTIVES: To assess the quality of mammography women receive at facilities characterized as serving a hig…
Accuracy of Diagnostic Mammography at Facilities Serving Vulnerable Women
BACKGROUND: Breast cancer missed on diagnostic mammography may contribute to delayed diagnoses, whereas false-positive results may lead to unnecessary invasive procedures. Whether accuracy of diagnostic mammography at facilities serving vulnerable women differs from other facilities is unknown. OBJECTIVE: To compare the interpretive performance of diagnostic mammography at facilities serving vulnerable women to those serving nonvulnerable women. …
Facility Characteristics do not Explain Higher False-positive Rates in Diagnostic Mammography at Facilities Serving Vulnerable Women
BACKGROUND: Facilities serving vulnerable women have higher false-positive rates for diagnostic mammography than facilities serving nonvulnerable women. False positives lead to anxiety, unnecessary biopsies, and higher costs. OBJECTIVE: Examine whether availability of on-site breast ultrasound or biopsy services, academic medical center affiliation, or profit status explains differences in false-positive rates. DESIGN: We examined 78,733 diagnost…
Distinguishing Screening From Diagnostic Mammograms Using Medicare Claims Data
BACKGROUND: Medicare claims data may be a fruitful data source for research or quality measurement in mammography. However, it is uncertain whether claims data can accurately distinguish screening from diagnostic mammograms, particularly when claims are not linked with cancer registry data. OBJECTIVES: To validate claims-based algorithms that can identify screening mammograms with high positive predictive value (PPV) in claims data with and witho…
Cost Analysis of the STONE Randomized Trial
BACKGROUND: Decreasing the use of high-cost tests may reduce health care costs. OBJECTIVE: To compare costs of care for patients presenting to the emergency department (ED) with suspected kidney stones randomized to 1 of 3 initial imaging tests. RESEARCH DESIGN: Patients were randomized to point-of-care ultrasound (POC US, least costly), radiology ultrasound (RAD US), or computed tomography (CT, most costly). Subsequent testing and treatment were…
Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography
BACKGROUND: The breast cancer detection rate is a benchmark measure of screening mammography quality, but its computation requires linkage of mammography interpretive performance information with cancer incidence data. A Medicare claims-based measure of detected breast cancers could simplify measurement of this benchmark and facilitate mammography quality assessment and research. OBJECTIVES: To validate a claims-based algorithm that can identify …
Medicine (7 works) · Breast cancer (6 works) · Cancer (6 works) · Global Cancer Incidence and Screening (6 works) · Internal Medicine (6 works) · Internal Medicine (6 works) · Mammography (6 works) · Digital Radiography and Breast Imaging (5 works) · Confidence interval (4 works) · Breast Lesions and Carcinomas (3 works)